ウィスコンシンにおける濾胞性リンパ腫の臨床試験
ウィスコンシン内の拠点で、濾胞性リンパ腫に関する21件の研究が参加者を募集しています。
ウィスコンシン内の都市
公式研究テキスト（英語）
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
- Froedtert Menomonee Falls Hospital, Menomonee Falls
- Medical College of Wisconsin, Milwaukee
- ProHealth D N Greenwald Center, Mukwonago
- 他5件
被験者募集中第3相
12歳以上 · 全性別 · 2026/10/02更新 · NCT07215910Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
- Children's Hospital of Wisconsin, Milwaukee
被験者募集中観察研究
0歳〜38歳 · 全性別 · 2026/10/01更新 · NCT06131801Buprenorphine Implementation at Syringe Service Programs to Reduce Overdoses
- Vivent Health, Milwaukee
被験者募集中健康なボランティア歓迎
18歳以上 · 全性別 · 2026/10/01更新 · NCT07631598A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
- Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07226843A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
- Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07101328A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
- Research Site, Madison
- Research Site, Milwaukee
被験者募集中第3相
18歳〜130歳 · 全性別 · 2026/09/21更新 · NCT06549595Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
- Research Site, Milwaukee
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/11更新 · NCT06526793Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/02更新 · NCT06860594SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- University of Wisconsin Health, Madison
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/28更新 · NCT05303519A Study of ARC-02 in B-cell NHL
- Froedtert & Medical College of Wisconsin, Milwaukee
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/26更新 · NCT07691606Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
- Medical College of Wisconsin, Milwaukee
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/25更新 · NCT05826535A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma
- Prohealth Care Inc, Waukesha
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/14更新 · NCT06149286LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies
- Froedtert & the Medical College of Wisconsin, Milwaukee
被験者募集中第1相
18歳〜81歳 · 全性別 · 2026/08/06更新 · NCT05990465A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
- Medical College of Wisconsin, Milwaukee
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/02更新 · NCT05131022Epcoritamab and Rituximab for First-line Follicular Lymphoma
- Medical College of Wisconsin, Milwaukee
被験者募集中第2相
18歳以上 · 全性別 · 2026/05/22更新 · NCT05783609CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies
- Medical College of Wisconsin and Froedtert Hospital, Milwaukee
被験者募集中第1/2相
18歳〜80歳 · 全性別 · 2026/02/23更新 · NCT04186520Study of SGR-1505 in Mature B-Cell Neoplasms
- Medical College of Wisconsin, Milwaukee
被験者募集中第1相
18歳以上 · 全性別 · 2026/02/13更新 · NCT05544019AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
- The Medical College of Wisconsin, Milwaukee
被験者募集中第1相
18歳以上 · 全性別 · 2025/12/10更新 · NCT05602363Long-term Follow-up Study of Patients Receiving CAR-T Cells
- Froedtert Hospital & Medical College of Wisconsin, Milwaukee
被験者募集中観察研究
18歳〜80歳 · 全性別 · 2025/11/10更新 · NCT03375619SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Milwaukee
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774A Study to Patients With Relapsed/Refractory Follicular Lymphoma Treated With Liso-cel (Lisocabtagene Maraleucel) in the Post Marketing Setting
- CIBMTR, Milwaukee
被験者募集中観察研究
18歳以上 · 全性別 · 2025/02/24更新 · NCT06794268ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。